The history of Viagra, originally marketed by copyright, presents a complex case study for investors considering the pharmaceutical sector. Although its groundbreaking success and creation of billions in revenue , the exclusivity lapse has opened the floodgates for alternative medications, substantially reducing profit potential . This change raise